Simcere Pharmaceutical Group Management
Management criteria checks 2/4
Simcere Pharmaceutical Group's CEO is Jinsheng Ren, appointed in Mar 1995, has a tenure of 29.17 years. total yearly compensation is CN¥7.43M, comprised of 67.6% salary and 32.4% bonuses, including company stock and options. directly owns 4.84% of the company’s shares, worth €84.48M. The average tenure of the management team and the board of directors is 1.5 years and 4.5 years respectively.
Key information
Jinsheng Ren
Chief executive officer
CN¥7.4m
Total compensation
| CEO salary percentage | 67.6% |
| CEO tenure | 29.2yrs |
| CEO ownership | 4.8% |
| Management average tenure | 1.5yrs |
| Board average tenure | 4.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | CN¥7m | CN¥5m | CN¥715m |
| Sep 30 2023 | n/a | n/a | CN¥2b |
| Jun 30 2023 | n/a | n/a | CN¥3b |
| Mar 31 2023 | n/a | n/a | CN¥2b |
| Dec 31 2022 | CN¥3m | CN¥2m | CN¥931m |
| Sep 30 2022 | n/a | n/a | CN¥972m |
| Jun 30 2022 | n/a | n/a | CN¥1b |
| Mar 31 2022 | n/a | n/a | CN¥1b |
| Dec 31 2021 | CN¥2m | CN¥2m | CN¥2b |
| Sep 30 2021 | n/a | n/a | CN¥1b |
| Jun 30 2021 | n/a | n/a | CN¥1b |
| Mar 31 2021 | n/a | n/a | CN¥856m |
| Dec 31 2020 | CN¥2m | CN¥1m | CN¥670m |
| Sep 30 2020 | n/a | n/a | CN¥699m |
| Jun 30 2020 | n/a | n/a | CN¥728m |
| Mar 31 2020 | n/a | n/a | CN¥866m |
| Dec 31 2019 | CN¥2m | CN¥1m | CN¥1b |
Compensation vs Market: Jinsheng's total compensation ($USD1.03M) is below average for companies of similar size in the German market ($USD1.61M).
Compensation vs Earnings: Jinsheng's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Jinsheng Ren (61 yo)
29.2yrs
Tenure
CN¥7,426,000
Compensation
Mr. Jinsheng Ren founded Simcere Pharmaceutical Group Limited in March 1995 and its Chairman since 2023 and serves as its Director and also serves as its Chief Executive Officer since November 19, 2019 an...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 29.2yrs | CN¥7.43m | 4.84% CN¥ 84.5m | |
| CFO, Joint Company Secretary & Executive Director | 4.5yrs | CN¥9.36m | 0.048% CN¥ 835.2k | |
| Executive Director | 1.3yrs | CN¥14.53m | 0.060% CN¥ 1.1m | |
| VP & Executive Director | 1.3yrs | CN¥1.33m | no data | |
| Chief Investment Officer | 1.3yrs | no data | no data | |
| Vice President of Marketing | no data | no data | no data | |
| Chief Operating Officer of Simcere Zaiming | 2.1yrs | no data | no data | |
| Senior VP & Chief Scientific Officer of U.S. | 1.7yrs | no data | no data | |
| Senior VP & Chief Medical Officer | less than a year | no data | no data | |
| Senior Vice President | less than a year | no data | no data | |
| Joint Company Secretary | 3.7yrs | no data | no data |
1.5yrs
Average Tenure
48yo
Average Age
Experienced Management: S2P's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 8.5yrs | CN¥7.43m | 4.84% CN¥ 84.5m | |
| CFO, Joint Company Secretary & Executive Director | 4.5yrs | CN¥9.36m | 0.048% CN¥ 835.2k | |
| Executive Director | 4.5yrs | CN¥14.53m | 0.060% CN¥ 1.1m | |
| VP & Executive Director | 1.3yrs | CN¥1.33m | no data | |
| Independent Non-Executive Director | 4.5yrs | CN¥360.00k | no data | |
| Independent Non-Executive Director | 4.5yrs | CN¥360.00k | no data | |
| Independent Non-Executive Director | 4.5yrs | CN¥360.00k | no data | |
| Independent Non-Executive Director | 1.3yrs | CN¥360.00k | no data |
4.5yrs
Average Tenure
56yo
Average Age
Experienced Board: S2P's board of directors are considered experienced (4.5 years average tenure).